1) compound ointment of testosterone propionas
复方丙睾软膏
2) testosteroni propionas ointment
丙酸睾丸酮软膏
1.
During and after the course of making model, Ru ning Waifu ointment and testosteroni propionas ointment were used on the breast.
在制模过程中和制模成功后分别使用乳宁外敷膏和丙酸睾丸酮软膏外贴乳房部位 ,对照观察乳房外观形态、组织学形态和血浆中雌二醇的含量。
3) Compound onitment
复方软膏
4) Compound Clobetasol Propionate Ointment
复方丙酸氯倍他索软膏
1.
METHODS:A total of 180 patients with psoriasis were randomly assigned to four groups:Group A(Yinxie tablets+10% boric acid ointment),Group B(Yinxie tablets+Compound Clobetasol Propionate Ointment),Group C(Compound Ampeptide Elemente tablets+10% boric acid ointment),and Group D(Compound Ampeptide Elemente tablets+Compound Clobetasol Propionate Ointment).
方法:180例银屑病患者随机分为4组,分别给予银屑片+10%硼酸软膏(A组)、银屑片+复方丙酸氯倍他索软膏(B组)、复方氨肽素片+10%硼酸软膏(C组)、复方氨肽素片+复方丙酸氯倍他索软膏(D组)治疗,运用成本-效果方法进行评价。
5) Compound Benzoic Acid Ointment
复方苯甲酸软膏
1.
Simultaneous Determination of Benzoic Acid and Salicylic Acid in Compound Benzoic Acid Ointment by K-Factor UV Spectrophotometry;
系数倍率紫外光谱法同时测定复方苯甲酸软膏中的苯甲酸和水杨酸的研究
2.
OBJECTIVE:To develop a RP-HPLC method for simultaneous determination of benzoic acid and salicylic acid in compound benzoic acid ointment.
目的 :建立以高效液相色谱法同时测定复方苯甲酸软膏中苯甲酸和水杨酸含量的方法。
6) Compound Flumetasone Ointment
复方氟米松软膏
1.
Compound Flumetasone Ointment for Neurodermatitis:Clinical Observation;
复方氟米松软膏治疗神经性皮炎临床观察
2.
d) combined with NB-UVB(systemic irradiation every other day) for two months(trial group,n=47) or Compound Flumetasone ointment(applied locally b.
冰黄肤乐软膏涂擦患处,每日2次;采用NB-UVB治疗仪全身照射,隔日1次,总疗程2个月;对照组采用复方氟米松软膏联合窄谱中波紫外线治疗,NB-UVB治疗仪全身照射方法与观察组相同,复方氟米松软膏涂擦患处,每日2次;治疗结束后观察疗效。
3.
METHODS: One hundred patients with chronic either eczema or neurodermatitis were randomly divided into two groups: 50 cases in the treatment group were treated with Compound Flumetasone ointment(bid,topically)plus Cetirizine or Loratadine tablets(10mg per day,orally)for 4 weeks;while 50 cases in the control group were treated with Mometasone Furoate ointment(q.
目的:观察复方氟米松软膏治疗慢性湿疹、神经性皮炎的临床疗效。
补充资料：丙睾
分子式：暂无
分子量：暂无
CAS号：57-85-2
性质：暂无
制备方法：暂无
用途：用于治疗乳腺癌、卵巢癌、子宫肌瘤、多发性骨髓瘤及肾癌等。
分子量：暂无
CAS号：57-85-2
性质：暂无
制备方法：暂无
用途：用于治疗乳腺癌、卵巢癌、子宫肌瘤、多发性骨髓瘤及肾癌等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条